Mutant superoxide dismutase 1 (SOD1), a cause of amyotrophic lateral sclerosis, disrupts the recruitment of SMN, the spinal muscular atrophy protein to nuclear Cajal bodies.

Human Molecular Genetics
Shingo KariyaUmrao R Monani

Abstract

Spinal muscular atrophy (SMA) and amyotrophic lateral sclerosis (ALS) are among the most common motor neuron diseases to afflict the human population. A deficiency of the survival of motor neuron (SMN) protein causes SMA and is also reported to be an exacerbating factor in the development of ALS. However, pathways linking the two diseases have yet to be defined and it is not clear precisely how the pathology of ALS is aggravated by reduced SMN or whether mutant proteins underlying familial forms of ALS interfere with SMN-related biochemical pathways to exacerbate the neurodegenerative process. In this study, we show that mutant superoxide dismutase-1 (SOD1), a cause of familial ALS, profoundly alters the sub-cellular localization of the SMN protein, preventing the formation of nuclear 'gems' by disrupting the recruitment of the protein to Cajal bodies. Overexpressing the SMN protein in mutant SOD1 mice, a model of familial ALS, alleviates this phenomenon, most likely in a cell-autonomous manner, and significantly mitigates the loss of motor neurons in the spinal cord and in culture dishes. In the mice, the onset of the neuromuscular phenotype is delayed and motor function enhanced, suggestive of a therapeutic benefit for ALS pa...Continue Reading

References

Jan 31, 1995·Proceedings of the National Academy of Sciences of the United States of America·M E RippsJ W Gordon
Aug 1, 1997·Human Molecular Genetics·D D CoovertA H Burghes
Jul 24, 2001·Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases·Y WatanabeK Nakashima
Aug 15, 2002·Cell·Hynek WichterleThomas M Jessell
Oct 16, 2002·The Journal of Cell Biology·Stephen C Ogg, Angus I Lamond
Jan 23, 2004·Experimental Neurology·Lindsey R FischerJonathan D Glass
Feb 14, 2006·Current Neurology and Neuroscience Reports·Peter M Andersen
Apr 1, 2006·Chromosoma·David Stanek, Karla M Neugebauer
Aug 25, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Thomas W GouldRonald W Oppenheim
Aug 26, 2006·Neurology·P CorciaUNKNOWN French ALS Study Group
Apr 17, 2007·Nature Neuroscience·Francesco Paolo Di GiorgioKevin Eggan
Apr 17, 2007·Nature Neuroscience·Makiko NagaiSerge Przedborski
Mar 19, 1993·Science·S Subbiah
Oct 30, 2007·Biochemical and Biophysical Research Communications·Tie ZouJianhua Zhou
Feb 5, 2008·Nature Neuroscience·Koji YamanakaDon W Cleveland
Feb 29, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Dick JaarsmaCasper C Hoogenraad
Aug 30, 2008·Biochimica Et Biophysica Acta·Glenn E Morris
Apr 13, 2011·Archives of Neurology·Stephen J Kolb, John T Kissel
Jun 16, 2011·Human Molecular Genetics·Thanh T LeArthur H M Burghes
Jul 26, 2011·The Journal of Clinical Investigation·Cathleen M LutzUmrao R Monani
Nov 5, 2011·Nature Reviews. Neurology·Laura FerraiuoloPamela J Shaw
Feb 11, 2012·Neurology·H M BlauwL H van den Berg

❮ Previous
Next ❯

Citations

Jun 13, 2013·Proceedings of the National Academy of Sciences of the United States of America·Anindya SenSpyros Artavanis-Tsakonas
May 18, 2013·Human Molecular Genetics·Ewout J N GroenR Jeroen Pasterkamp
Dec 21, 2012·EMBO Molecular Medicine·Hitomi TsuijiKoji Yamanaka
May 16, 2013·Acta Neuropathologica·Anna M BlokhuisR Jeroen Pasterkamp
Jul 6, 2014·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Tomoyuki AwanoUmrao R Monani
Mar 22, 2014·CNS Neuroscience & Therapeutics·Ruben J Cauchi
Jan 19, 2016·Brain Pathology·Simona RossiMaria Teresa Carrì
Oct 2, 2012·Cell Reports·Tomohiro YamazakiRobin Reed
May 18, 2016·Scientific Reports·Ilary AllodiEva Hedlund
Sep 16, 2016·RNA Biology·Miguel LafargaMaria T Berciano
Mar 3, 2017·Disease Models & Mechanisms·Masaki KobayashiDouglas W Zochodne
May 9, 2014·Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration·Shingo KariyaHiroshi Mitsumoto
Sep 8, 2017·Cellular and Molecular Life Sciences : CMLS·Vanesa LafargaMaria T Berciano
Dec 23, 2017·Frontiers in Molecular Neuroscience·Andrew P Tosolini, James N Sleigh
Jul 8, 2014·Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration·Laura AlíasEduardo F Tizzano
May 5, 2020·Annals of Clinical and Translational Neurology·Ana T MarcosPedro A Lazo
Sep 13, 2017·Antioxidants & Redox Signaling·Nadia D'AmbrosiMaria Teresa Carrì
Jul 24, 2014·Journal of Cell Science·Eva Stejskalová, David Staněk

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cajal Bodies & Gems

Cajal bodies or coiled bodies are dense foci of coilin protein. Gemini of Cajal bodies, or gems, are microscopically similar to Cajal bodies. It is believed that Cajal bodies play important roles in RNA processing while gems assist the Cajal bodies. Find the latest research on Cajal bodies and gems here.

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating genetic alterations in this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.